| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 228,572 | | Cost of Revenue | 64,393 | | | Gross Profit | 164,179 | | | Operating Expenses | | Research Development | 6,687 | | Selling General and Administrative | 184,458 | | Non Recurring | 136,661 | | Others | 51,403 | | | | Total Operating Expenses | 379,209 | | | | Operating Income or Loss | (215,030) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 130 | | Earnings Before Interest And Taxes | (214,900) | | Interest Expense | 650 | | Income Before Tax | (215,550) | | Income Tax Expense | (13,274) | | Minority Interest |
-
| | | | Net Income From Continuing Ops | (202,276) | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | (202,276) | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | ($202,276) |
|
0.34% Nasdaq 
Income Statement
